Agile Therapeutics Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
19
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$45M
- Investors
-
2
Agile Therapeutics General Information
Description
Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. The Company views its operations and manages its business in one operating and reporting segment, which is the business of commercializing its transdermal patch for use in contraception.
Contact Information
Website
agiletherapeutics.com(Operating Subsidiary)
Corporate Office
- 500 College Road East
- Suite 310
- Princeton, NJ 08540
- United States
Corporate Office
- 500 College Road East
- Suite 310
- Princeton, NJ 08540
- United States
Agile Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 20. Merger/Acquisition | 26-Aug-2024 | $45M | Completed | Generating Revenue | ||
| 19. PIPE | 01-Jul-2022 | Completed | Generating Revenue | |||
| 18. Debt - General | 10-Feb-2020 | Completed | Generating Revenue | |||
| 17. Secondary Transaction - Open Market | Completed | Generating Revenue | ||||
| 16. PIPE | 04-Mar-2019 | Completed | Generating Revenue | |||
| 15. Secondary Transaction - Private | 18-May-2018 | Completed | Generating Revenue | |||
| 14. PIPE | 22-Oct-2015 | Completed | Generating Revenue | |||
| 13. 2PO | 13-Jul-2015 | Completed | Generating Revenue | |||
| 12. Debt Refinancing | 25-Feb-2015 | $25M | $222M | Completed | Generating Revenue | |
| 11. PIPE | 23-Jan-2015 | $4.75M | $197M | Completed | Generating Revenue |
Agile Therapeutics Comparisons
Industry
Financing
Details
Agile Therapeutics Competitors (53)
One of Agile Therapeutics’s 53 competitors is Intas Pharmaceuticals, a Private Equity-Backed company based in Ahmedabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
| Northwest Biotherapeutics | Corporation | Bethesda, MD | ||||
| Grifols | Corporation | Barcelona, Spain | ||||
| Esperion Therapeutics | Private Equity-Backed | Ann Arbor, MI | ||||
| EyePoint | Corporation | Watertown, MA |
Agile Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Agile Therapeutics Patents
Agile Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2018235778-A1 | Personalized contraceptive formulations | Active | 15-Mar-2017 | ||
| AU-2018235778-B2 | Personalized contraceptive formulations | Active | 15-Mar-2017 | ||
| CA-3056210-A1 | Personalized contraceptive formulations | Pending | 15-Mar-2017 | ||
| EP-3595597-A1 | Personalized contraceptive formulations | Pending | 15-Mar-2017 | ||
| EP-3595597-A4 | Personalized contraceptive formulations | Pending | 15-Mar-2017 | A61K9/7023 |
Agile Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Agile Therapeutics Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aisling Capital | Venture Capital | Minority | ||
| CAM Capital | Asset Manager | Minority | ||
| Care Capital | Venture Capital | Minority | ||
| Foresite Capital | Growth/Expansion | Minority | ||
| Hillman Solutions | Corporation | Minority |
Agile Therapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Agile Therapeutics FAQs
-
When was Agile Therapeutics founded?
Agile Therapeutics was founded in 1997.
-
Where is Agile Therapeutics headquartered?
Agile Therapeutics is headquartered in Princeton, NJ.
-
What is the size of Agile Therapeutics?
Agile Therapeutics has 19 total employees.
-
What industry is Agile Therapeutics in?
Agile Therapeutics’s primary industry is Pharmaceuticals.
-
Is Agile Therapeutics a private or public company?
Agile Therapeutics is a Private company.
-
What is the current valuation of Agile Therapeutics?
The current valuation of Agile Therapeutics is .
-
What is Agile Therapeutics’s current revenue?
The current revenue for Agile Therapeutics is .
-
How much funding has Agile Therapeutics raised over time?
Agile Therapeutics has raised $301M.
-
Who are Agile Therapeutics’s investors?
Aisling Capital, CAM Capital, Care Capital, Foresite Capital, and Hillman Solutions are 5 of 14 investors who have invested in Agile Therapeutics.
-
Who are Agile Therapeutics’s competitors?
Intas Pharmaceuticals, Northwest Biotherapeutics, Grifols, Esperion Therapeutics, and EyePoint are some of the 53 competitors of Agile Therapeutics.
-
When was Agile Therapeutics acquired?
Agile Therapeutics was acquired on 26-Aug-2024.
-
Who acquired Agile Therapeutics?
Agile Therapeutics was acquired by Exeltis USA (Pharmaceuticals).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
